GRIŠČÍKOVÁ, Lenka, Rudolf AUTRATA, Inka KREJČÍŘOVÁ, Jorge L. ALIÓ, Barbora ŽAJDLÍKOVÁ, Dana TOMČÍKOVÁ and Martin HLOŽÁNEK. Anterior Chamber Iris-Fixated Phakic Intraocular Lens Implantation for Treatment of High Anisometropia in Children: Long-term Results. JOURNAL OF PEDIATRIC OPHTHALMOLOGY & STRABISMUS. THOROFARE: SLACK INC, 2023, vol. 60, No 3, p. 203-209. ISSN 0191-3913. Available from: https://dx.doi.org/10.3928/01913913-20220610-02.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Anterior Chamber Iris-Fixated Phakic Intraocular Lens Implantation for Treatment of High Anisometropia in Children: Long-term Results
Authors GRIŠČÍKOVÁ, Lenka (703 Slovakia, guarantor, belonging to the institution), Rudolf AUTRATA (203 Czech Republic, belonging to the institution), Inka KREJČÍŘOVÁ (203 Czech Republic, belonging to the institution), Jorge L. ALIÓ, Barbora ŽAJDLÍKOVÁ (203 Czech Republic, belonging to the institution), Dana TOMČÍKOVÁ (203 Czech Republic) and Martin HLOŽÁNEK (203 Czech Republic).
Edition JOURNAL OF PEDIATRIC OPHTHALMOLOGY & STRABISMUS, THOROFARE, SLACK INC, 2023, 0191-3913.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30207 Ophthalmology
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 1.200 in 2022
RIV identification code RIV/00216224:14110/23:00130141
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.3928/01913913-20220610-02
UT WoS 000838851100001
Keywords in English High Anisometropia; Children; Anterior Chamber Iris-Fixated Phakic Intraocular Lens Implantation
Tags 14110315, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 26/1/2024 10:35.
Abstract
Purpose: To evaluate the long-term efficacy of anterior chamber iris-fixated phakic intraocular lens (PIOL) implantation in the treatment of high myopic (> -9.00 diopters [D]) or hyperopic (> +6.00 D) anisometropia in children with intolerance to spectacles or contact lenses. Methods: A total of 58 children with anisometropic myopia (range: -9.25 to-18.50 diopters [D]) and 13 children with anisometropic hyperopia (range: +6.00 to +8.50 D) underwent unilateral iris-claw PIOL implantation from 2008 to 2018. The mean age was 6.7 years. The mean follow-up was 38.5 months. Target refraction was emmetropia. Results: The cycloplegic refraction (mean spherical equivalent) improved from -12.47 D (range:-9.25 to-18.50 D) to -0.73 D (range: +0.75 to -1.50 D) in myopic eyes and reduced from +7.15 D (range: +6.00 to +8.50 D) to +0.94 D (range: -0.50 to + 1.75 D) in hyperopic eyes. Eighty-four percent of eyes were corrected to within +/- 1.00 D of emmetropia. The mean uncorrected distance visual acuity (UDVA) improved from 1.74 +/- 0.36 to 0.45 +/- 0.28 logarithm of the minimum angle of resolution (logMAR) (P = .0014). The mean corrected distance visual acuity (CDVA) changed from 0.68 +/- 0.32 to 0.27 +/- 0.15 logMAR (P = .02179). The safety index was 2.18 and the efficacy index was 1.51. The mean preoperative endothelial cell count of 2,874.7 cells/mm(2) changed to 2,685.3 cells/mm(2) at 2 to 6 years postoperatively. Binocular vision quality was improved in 55 patients. No patient had serious complications or lost any Snellen lines of CDVA. Conclusions: Iris-fixated PIOL implantation is an effective and safe method in the treatment of high anisometropic myopia and hyperopia and amblyopia in pediatric patients who are noncompliant with spectacles or contact lenses.
PrintDisplayed: 2/7/2024 11:01